SCHEMBL30052151

SCHEMBL30052151

Nc1cccc2c1ccn2CC(=O)O

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.56
PARP1 P09874 1/20 0.52
PPARG P37231 4/20 0.48
PPARA Q07869 4/20 0.48
STAT3 P40763 1/20 0.44
KDM4E B2RXH2 4/20 0.43
TBXAS1 P24557 1/20 0.43
ALDH1A1 P00352 3/20 0.42
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
ALOX12 P18054 1/20 0.41
RECQL P46063 1/20 0.41
PPARD Q03181 2/20 0.41
GLA P06280 2/20 0.40
RHEB Q15382 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3174313 1.00 KMT2A (0.56) KMT2APARP1PPARGPPARASTAT3
SCHEMBL14876467 0.81 GAA (0.51) KMT2APARP1KDM4EALDH1A1MEN1
SCHEMBL3169119 0.81 KMT2A (0.57) KMT2APPARGPPARASTAT3KDM4E
SCHEMBL13065371 0.80 KMT2A (0.56) KMT2APPARGPPARASTAT3KDM4E
SCHEMBL12875609 0.80 KMT2A (0.56) KMT2APPARGPPARASTAT3KDM4E
SCHEMBL20037232 0.80 KMT2A (0.56) KMT2APPARGPPARASTAT3KDM4E
SCHEMBL3913002 0.79 ALDH1A1 (0.52) KMT2AKDM4EALDH1A1MEN1LMNA
SCHEMBL29612923 0.79 ALDH1A1 (0.52) KMT2AKDM4EALDH1A1MEN1LMNA
SCHEMBL2777064 0.76 STAT3 (0.67) KMT2APPARGPPARASTAT3KDM4E
SCHEMBL15157114 0.76 HTR2C (0.57) KMT2APPARGPPARAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4125914-A1 PYRROLOPYRIMIDINE AMINES AS COMPLEMENT INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2023-02-08 EP disclosed
CN-115427044-A Pyrrolopyrimidines as complement inhibitors 拜奥克里斯特制药公司 2022-12-02 CN disclosed